NNLX news after bell
SHARON, Pa., June 22 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC Pink Sheets:
NNLX), a nanobiotechnology company engaged in the development and
commercialization of technologies for the creation of hydrogen utilizing
hydrogen bioreactors, announced today that it has signed an agreement for the
construction and operation of a prototype hydrogen bioreactor at the City of
Erie wastewater treatment plant. This project will utilize the proprietary
intellectual property of NanoLogix in conjunction with the participation of
faculty members and students from Gannon University. Mitchell S. Felder, M.D.,
CEO of NanoLogix, Inc., stated that, "We are very enthusiastic about exploring
the enormous potential for converting wastewater into hydrogen. The Erie
Wastewater Treatment Plant treats between 30-40 million gallons per day from the
sewer system. There are thousands of plants throughout America. Success in
this arena could greatly alleviate American dependence upon foreign energy
sources." Joe Sinnott, Esq., the Mayor of Erie, added, "We are proud to have
the City of Erie in the forefront of the technological fight for American energy
independence. Our collective success could permanently change the worldwide
energy paradigm."
About NanoLogix, Inc.
NanoLogix is a nano-biotechnology company whose extensive portfolio of patents
have application and marketability in the following areas:
nanoscale microfluidics for the rapid identification of disease causing
pathogens utilizing BioMEMS; production of high value hydrogen from
agricultural feedstock, industrial waste water and municipal waste streams;
nontoxic induction of apoptosis (a method for inducing a genetically based
induction of "cell suicide") in cancer cells utilizing hydrophobic hydrocarbons;
and the bio-remediation of air, water and soils of harmful contaminants.
